相关实验视频
Updated: Jul 1, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
在COVID-19期间进行家庭血红蛋白A1c测试,改善了血糖控制
Lauren C LaMonica, Jingwei Ren, Nina Jain
1CVS Health, 93 Worcester St, Wellesley, MA 02482.
The American journal of managed care
|March 8, 2024
概括
在家用血红蛋白A1c (HbA1c) 检测套件有效地提高了2型糖尿病管理的检测频率. 这种干预也导致了患者的HbA1c水平显著降低.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- COVID-19使得常规慢性疾病管理测试的准入变得更加糟糕.
- 血红蛋白A1c (HbA1c) 测试对于监测2型糖尿病 (T2D) 至关重要.
- 定期HbA1c测试的障碍影响T2D患者的结果.
研究的目的:
- 为了评估家用HbA1c测试工具是否会增加测试频率.
- 为了确定这些套件是否导致HbA1c水平的变化,测试后6个月.
- 评估自我强化教育是否有助于持续的HbA1c测试.
主要方法:
- 一个随机的,受控的质量改进干预的回顾性分析.
- 涉及41,214个T2D的商业成员.
- 干预组在家中接受了选择/选择退出HbA1c套件或自我强化信息.
主要成果:
- 与对照组相比,在家用HbA1c套件的测试率增加了4.9%.
- 在家中完成测试的成员显示HbA1c降低了0.38%.
- 自强化信息导致HbA1c降低0.37%.
结论:
- 在家HbA1c测试是提高T2D患者测试率的有效干预措施.
- 这种方法有助于随着时间的推移降低HbA1c.
- 家庭测试为改善慢性疾病管理提供了一种新的解决方案.
更多相关视频
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.8K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
221
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
534
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260